EX-10.6 3 d928233dex106.htm EX-10.6 EXECUTION COPY Date: 26 June 2003 ELAN CORPORATION, PLC. AND WATSON LABORATORIES, INC. AMENDED AND RESTATED LICENCE AND SUPPLY AGREEMENT (VERAPAMIL)Licence and Supply Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Date: 26 June 2003 ELAN CORPORATION, PLC. AND WATSON LABORATORIES, INC. AMENDED AND RESTATED LICENCE AND SUPPLY AGREEMENT (VERAPAMIL)Licence and Supply Agreement • August 14th, 2015 • Recro Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 14th, 2015 Company Industry JurisdictionIn the event that Elan acquires or merges with a third party entity, Elan Know-How shall not include any know-how to the extent that such know-how relates to a product containing the same active ingredient as the DSDF which has been approved for marketing or is in development by the said third party entity at the time of such acquisition or merger. For the avoidance of doubt, the occurrence of any such acquisition or merger shall not affect the license of the Elan Know-How granted to Watson hereunder.